Company Flexion Therapeutics, Inc.
Equities
FLXN
US33938J1060
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Compliance Officer | - | 16-08-31 | |
Scott A. Young
IRC | Investor Relations Contact | - | 16-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,321,366 | 48,104,888 ( 95.60 %) | 0 | 95.60 % |
Company contact information
Flexion Therapeutics, Inc.
10 Mall Road Suite 301
01803, Burlington
+781 305 7777
http://www.flexiontherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |